Puma Biotechnology, Inc.PBYINASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank79
3Y CAGR+16.3%
5Y CAGR-6.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+16.3%/yr
vs -28.0%/yr prior
5Y CAGR
-6.3%/yr
Recent acceleration
Acceleration
+44.2pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.30 | +102.4% |
| 2024 | 0.64 | -25.7% |
| 2023 | 0.87 | +4.5% |
| 2022 | 0.83 | +69.8% |
| 2021 | 0.49 | -72.9% |
| 2020 | 1.80 | +44.8% |
| 2019 | 1.25 | -59.5% |
| 2018 | 3.08 | -97.7% |
| 2017 | 132.64 | - |
| 2016 | 0.00 | - |